Hycamtin Combo Therapy Approved For Late-Stage Cervical Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline’s topotecan demonstrates a survival benefit when used in combination with cisplatin, FDA says.